What is Camurus AB (publ)?
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain; and Brixadi to treat opioid use disorder. The company is listed on the OTCGREY in USA, operating in the Healthcare sector, with a market capitalisation of 3.77B, and a P/E ratio of 47.6x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.